View more job listings or post a job
Catalent Pharma Solutions - San Diego Position OverviewJob DescriptionCatalent hires people with a passion to make a difference to the health of millions of people globally. Your expertise, coupled with Catalent’s advance
Denali Therapeutics Principal Scientist, DMPK (small molecule therapeutics)
Sorrento Therapeutics Scientist/Senior Scientist, LC-MS
Takeda Principal Scientist, DMPK Project Representative, Oligos, Cell Therapy, Biologics
Cytokinetics Director/Sr. Director DMPK
Longboard Pharmaceuticals Director of ADME
CCS Associates, Inc. Senior Scientist, Immunology
TLL Pharma, High Impact Medicines for All.  Director of Formulation Development
Post a job


[Free Online Seminar] Fighting pancreatic cancer: current treatments, pipeline landscape, and PanCAN's drug development projects

Speakers: Anne-Marie Duliege, MD, Chief Medical Officer, Pancreatic Cancer Network (PanCAN)
Date: 2021-12-07
Time: 11:30-13:30 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration deadline:2021-12-07  (it will close sooner if the seating cap is reached)

About the Topic

Drug development in metastatic pancreatic ductal adenocarcinoma (PDAC) has been disappointing with a 5 year survival rate of only 10% despite considerable effort.  Precision Promise is a transformative, adaptive registration clinical trial platform that attempts to correct this by continuously and rapidly evaluating novel therapeutic options while nurturing enhanced cooperation among groups representing patient advocacy, pharmaceuticals, translational/clinical academia, and the FDA. This patient-centric study represents a fundamental shift that can substantially accelerate drug development for PDAC . PanCAN is also leading translational research by facilitating genetic testing of patients with pancreatic cancer (“Know Your Tumor” program), and has recently launched an Early Detection Initiative (EDI) in patients with recent onset diabetes.

About the Speakers

As Chief Medical Officer for the Pancreatic Cancer Action Network, Anne-Marie Duliege, MD, is responsible for the strategic direction and operational oversight for the organization’s clinical initiatives, including PanCAN’s Precision Promise‚Ą† clinical trial.

From 2004 to 2013, Dr. Duliege was VP then CMO and Head of Research and Clinical Development at Affymax. Under her leadership, her team completed an extensive development program and obtained FDA approval of the company’s lead product for anemia in dialysis patients. Prior to that, Dr. Duliege worked at Chiron and Genentech on various programs including an HIV vaccine and treatment. Prior to her career in the biopharmaceutical industry, Dr. Duliege was an epidemiologist with the National Institute of Science and Medical Research in Paris.

2021-09-23, [Free Online Symposium] Drug-Drug Interaction - Industry Trends and the 2020 FDA Guidances
2021-11-03, [Free Online Workshop] Nonclinical Reproductive Toxicity Studies: Fundamentals, Regulatory Trends and Case Studies
2021-11-17, [Free Online Symposium] Artificial Intelligence and Machine Learning to Drive Therapeutic Drug Discovery
©Pharmaceutical & BioScience Society, International; Last Modified: 9/18/2021; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

iPRECIO Programmable Pumps by Primetech Corporation Unprecedented PK-PD correlations in in-Vivo Pharmacology? Learn more on Linkedin- registration page. iPRECIO Programmable pump info at
Applied StemCell, Inc. Fresh & frozen non-human primate whole blood, PBMCs, T cells & more from cynomolgus & rhesus macaques. Animals housed in the U.S., Call 1-866-497-4180
Hypha Discovery Limited Synthesis, purification & NMR characterization of drug metabolites at mg-g scale with COAs, including CYP/AOX/FMO metabolites, glucuronides & sulfates
Applied StemCell, Inc. Fresh & frozen human PBMCs, CD34+ cells, NK cells, T cells & more. Customized sample collection and Bay Area same-day delivery are available.
Submit a Text Ad